Teladoc Health Inc. [NYSE: TDOC] closed the trading session at $33.76 on 04/29/22. The day’s price range saw the stock hit a low of $32.27, while the highest price level was $35.85. The company report on April 27, 2022 that Teladoc Health Reports First Quarter 2022 Results.
First quarter revenue grows 25% year-over-year to $565.4 million .
Net loss per share of $41.58, primarily driven by non-cash goodwill impairment charge of $6.6 billion or $41.11 per share.
The stocks have a year to date performance of -63.23 percent and weekly performance of -42.04 percent. The stock has been moved at -77.37 percent over the last six months. The stock has performed -53.80 percent around the most recent 30 days and changed -52.05 percent over the most recent 3-months.
If compared to the average trading volume of 5.75M shares, TDOC reached to a volume of 33615666 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Teladoc Health Inc. [TDOC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TDOC shares is $64.96 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TDOC stock is a recommendation set at 2.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Teladoc Health Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on April 28, 2022. While these analysts kept the previous recommendation, Wells Fargo raised their target price from $104 to $40. The new note on the price target was released on April 28, 2022, representing the official price target for Teladoc Health Inc. stock.
The Average True Range (ATR) for Teladoc Health Inc. is set at 5.79, with the Price to Sales ratio for TDOC stock in the period of the last 12 months amounting to 2.52. The Price to Book ratio for the last quarter was 0.34, with the Price to Cash per share for the same quarter was set at 5.60.
TDOC stock trade performance evaluation
Teladoc Health Inc. [TDOC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -42.04. With this latest performance, TDOC shares dropped by -53.80% in over the last four-week period, additionally sinking by -77.37% over the last 6 months – not to mention a drop of -80.41% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TDOC stock in for the last two-week period is set at 22.16, with the RSI for the last a single of trading hit 15.10, and the three-weeks RSI is set at 27.61 for Teladoc Health Inc. [TDOC]. The present Moving Average for the last 50 days of trading for this stock 64.76, while it was recorded at 48.32 for the last single week of trading, and 105.49 for the last 200 days.
Teladoc Health Inc. [TDOC]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Teladoc Health Inc. [TDOC] shares currently have an operating margin of -11.76 and a Gross Margin at +57.96. Teladoc Health Inc.’s Net Margin is presently recorded at -21.09.
Return on Equity for this stock declined to -2.69, with Return on Assets sitting at -2.35.
Teladoc Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.50 and a Current Ratio set at 3.70.
Teladoc Health Inc. [TDOC]: Insider Ownership positions
There are presently around $4,739 million, or 84.20% of TDOC stock, in the hands of institutional investors. The top three institutional holders of TDOC stocks are: ARK INVESTMENT MANAGEMENT LLC with ownership of 19,466,931, which is approximately 2.879% of the company’s market cap and around 0.50% of the total institutional ownership; VANGUARD GROUP INC, holding 13,140,062 shares of the stock with an approximate value of $443.61 million in TDOC stocks shares; and BAILLIE GIFFORD & CO, currently with $367.21 million in TDOC stock with ownership of nearly 23.528% of the company’s market capitalization.
Positions in Teladoc Health Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 339 institutional holders increased their position in Teladoc Health Inc. [NYSE:TDOC] by around 21,601,226 shares. Additionally, 389 investors decreased positions by around 18,223,958 shares, while 111 investors held positions by with 100,559,027 shares. The mentioned changes placed institutional holdings at 140,384,211 shares, according to the latest SEC report filing. TDOC stock had 101 new institutional investments in for a total of 7,641,062 shares, while 145 institutional investors sold positions of 8,178,807 shares during the same period.